Corrine Savill Net Worth & Insider Trades

Corrine Savill - Acting Chief Business Officer, Cullinan Oncology, Inc

As of July 21, 2022

What is Corrine Savill's Net Worth?

The current estimated net worth of Cullinan Oncology, Inc's Acting Chief Business Officer, Corrine Savill, is estimated to be about $3.49M . Corrine Savill owns about 149,615 units of Cullinan Oncology, Inc common stock. In the last 6 months at Cullinan Oncology, Inc, Corrine Savill has sold an estimated value of $836.9K worth.

What is Corrine Savill's Past Insider Trading?

Corrine Savill's largest sale order was 40,000 units , worth over $533.3K on July 12, 2022. In total, Corrine Savill has made about 3 transactions over 6 months of their time at Cullinan Oncology, Inc. Corrine Savill usually trades in July, with the busiest year in 2022. The most recent transaction was a sale order of 20,000 units , worth over $303.59K on July 21, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Corrine Savill's' Mailing Address?

  • Mailing address is C/o Cullinan Oncology, Llc One Main Street Suite 520 Cambridge MA 02142 MA

Cullinan Oncology, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Owen Hughes 2020 $461,250 $245,063 $530,320 $5,301,175 $14,250 $6,552,058
Owen Hughes 2019 $450,000 $96,800 - - $14,000 $560,800
Patrick Bauerle, Ph.D. 2020 $436,997 $266,131 $491,284 $4,124,284 $34,800 $5,353,497
Patrick Bauerle, Ph.D. 2019 $420,895 $107,502 - - $34,400 $562,797
Jon Wigginton, M.D. 2020 $321,122 $258,000 - $3,959,525 $5,375 $4,544,022
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1789972/000119312521140630/d170327ddef14a.htm

What are Cullinan Oncology, Inc's Past Insider Trades?

Cullinan Oncology, Inc's most recent insider trade came on September 29, 2022 by Jennifer Michaelson who sold 4,000 units worth $49.6K . In the last year, insiders at Cullinan Oncology, Inc have sold an estimated value of $28.93M and bought an estimated value of $39.25M worth of shares. Insider trading is most common in September, with the busiest year in 2021. The most active traders at the company are Ansbert Gadicke, Director,  Bioimpact Capital Llc,  and Jennifer Michaelson, See Remarks .

Cullinan Oncology, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1